Showing results (311-320 of 670) with videos related to
Sort By:
Pageof 67
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's diseaseM Mogi, M Harada, T Kondo, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1990
Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromineJ Fritze, E Sofic, H Pfüller, et al.FEBS Letters|July 15, 1999
High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expressionA Neumann, R Schinzel, D Palm, et al.Journal of Neurochemistry|September 1, 1994
Altered brain metabolism of iron as a cause of neurodegenerative diseases?M Gerlach, D Ben-Shachar, P Riederer, et al.Brain Research. Brain Research Reviews|February 1, 1997
Advanced glycation endproducts in ageing and Alzheimer's diseaseG Münch, J Thome, P Foley, et al.Annals of Neurology|January 1, 1992
Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's diseaseD Ben-Shachar, G Eshel, P Riederer, et al.Neurotoxicity Research|June 22, 2006
Strategies for the protection of dopaminergic neurons against neurotoxicityM Gerlach, K L Double, M B Youdim, et al.Neuroscience Letters|February 11, 1991
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?H Russ, W Mihatsch, M Gerlach, et al.Pharmacology & Therapeutics|January 1, 1994
Oxidative stress: free radical production in neural degenerationM E Götz, G Künig, P Riederer, et al.Journal of Psychiatry & Neuroscience : JPN|January 1, 1995
Cholinergic neurotransmission seems not to be involved in depression but possibly in personalityJ Fritze, M Lanczik, E Sofic, et al.Pageof 67